Clinical validation of indcyanine-green(ICG) fluorescence making in endoscopic esophagus/gastric cancer surgery.

Clinical validation of indcyanine-green(ICG) fluorescence making in endoscopic esophagus/gastric cancer surgery. - validation of ICG making in laparoscopic esophagus/gastric cancer surgery.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033085

Enrollment

Registered

2018-06-21

Start date

2018-03-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer and gastric cancer

Interventions

indocyanine green

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Initial esophageal cancer or gastric cancer case

Exclusion criteria

Exclusion criteria: 1) Cases with severe ischemic heart disease 2) Cases with complications of liver cirrhosis and active hepatitis 3) Cases with dyspnea requiring oxygen administration 4) Cases in which dialysis is performed in chronic renal failure 5) Cases requiring complication of other organs 6) Other cases that the physician judged as inappropriate

Design outcomes

Primary

Measure	Time frame
Tumor identification rate by ICG marking method	—

Secondary

Measure	Time frame
Safety (allergic reaction, incidence of perioperative complications)	—

Countries

Japan

Contacts

Public ContactTakayuki Nobuoka

Sapporo Medical University Department of Surgery, Surgical Oncology and Science

tnobu@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026